Cargando…
Loss of DSTYK activates Wnt/β-catenin signaling and glycolysis in lung adenocarcinoma
Aberrant activation of Wnt/β-catenin signaling and dysregulation of metabolism have been frequently observed in lung cancer. However, the molecular mechanism by which Wnt/β-catenin signaling is regulated and the link between Wnt/β-catenin signaling and cancer metabolism are not fully understood. In...
Autores principales: | Zhong, Chenxi, Chen, Ming, Chen, Yu, Yao, Feng, Fang, Wentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636471/ https://www.ncbi.nlm.nih.gov/pubmed/34853310 http://dx.doi.org/10.1038/s41419-021-04385-1 |
Ejemplares similares
-
DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021) -
DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
por: Zhang, Jinyu, et al.
Publicado: (2020) -
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
por: Valencia, Karmele, et al.
Publicado: (2022) -
Regulation of Wnt/β-catenin signaling by posttranslational modifications
por: Gao, Chenxi, et al.
Publicado: (2014) -
GOLPH3 Promotes Angiogenesis of Lung Adenocarcinoma by Regulating the Wnt/β-Catenin Signaling Pathway
por: Zhao, Canjun, et al.
Publicado: (2020)